Tina Sidoni

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models

Carlo Capalbo, Enrico Ricevuto, Annarita Vestri et al. · Annals of Oncology · 2006 · 42 citations

Medicine, Genetics, Oncology +16

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families

Amelia Buffone, Carlo Capalbo, Enrico Ricevuto et al. · Breast Cancer Research and Treatment · 2007 · 36 citations

Medicine, Genetics, Oncology +12

First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience

Alessandro Parisi, Eleonora Palluzzi, Alessio Cortellini et al. · Clinical & Translational Oncology · 2019 · 32 citations

Medicine, Oncology, Pharmacology +17

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

Giuseppe Giannini, Carlo Capalbo, Elisabetta Ristori et al. · Breast Cancer Research and Treatment · 2006 · 25 citations

Medicine, Genetics, Molecular Genetics +14

Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software

Carlo Capalbo, Enrico Ricevuto, Annarita Vestri et al. · European Journal of Human Genetics · 2005 · 21 citations · Full text

Life Sciences, Genetics, Molecular Genetics +9